Dow Down 3.39% Nasdaq Down 4.12%

Onconova Therapeutics, Inc. (ONTX)

-NasdaqCM
5.97 Down 0.18(2.93%) Jun 24, 4:00PM EDT
Prev Close:6.15
Open:6.07
Bid:4.40 x 300
Ask:7.00 x 2500
1y Target Est:3.50
Beta:-3.81445
Next Earnings Date:N/A
Day's Range:5.86 - 6.23
52wk Range:3.20 - 40.00
Volume:30,349
Avg Vol (3m):49,453
Market Cap:16.36M
P/E (ttm):N/A
EPS (ttm):-7.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ONTX

Comparison

Symbol% ChgMkt Cap
ONTXDown 2.93%16.36M
ARRYDown 3.63%494.88M
CELGDown 4.34%74.59B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-7.40
Quarterly EPS Est (Jun-16) :-1.60
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback